How many insider trades does FilingIQ track for MMED?

FilingIQ tracks 46 Form 4 insider transactions for MMED (MiniMed Group, Inc.), covering filings from Mar 9, 2026 onwards. 46 of those were filed in the last 90 days.

Are MMED insiders net buyers or net sellers?

Across the full Form 4 history for MMED, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MMED insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MMED in?

MiniMed Group, Inc. (MMED) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $5.07B.

MMED insider trading

NasdaqGS Healthcare

MiniMed Group, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$5.07B

About MiniMed Group, Inc.

Minimed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera, or Guardian 4, and wraparound applications and services. Minimed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. Minimed Group, Inc. operates as a subsidiary of Medtronic Global Holdings S.C.A.

Company website: www.minimed.com

MMED insider activity at a glance

FilingIQ has scored 46 insider transactions for MMED since Mar 9, 2026. The most recent filing in our index is dated Mar 25, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live MMED trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for MMED?: FilingIQ tracks 46 Form 4 insider transactions for MMED (MiniMed Group, Inc.), covering filings from Mar 9, 2026 onwards. 46 of those were filed in the last 90 days.
Are MMED insiders net buyers or net sellers?: Across the full Form 4 history for MMED, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MMED insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MMED in?: MiniMed Group, Inc. (MMED) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $5.07B.

Methodology & sources

Every MMED insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.